Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015)

Viking Therapeutics' (VKTX) quarterly Interest Expenses came in at $35253.0 in Q1 2015, up 1268.52% year-over-year from $2576.0 in Q1 2014, and up 1268.52% quarter-over-quarter from $2576.0 in Q1 2014.

Analysis

Viking Therapeutics (VKTX) Interest Expenses (2014 - 2015) Analysis & Trends

Viking Therapeutics has disclosed Interest Expenses across 2 years of filings, most recently posting $35253.0 for Q1 2015.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 281.00 Mn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -435.00 Mn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 247.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 35,253.00
Mar 31, 2014 2,576.00
API Access

Viking Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=VKTX&period=max&api_key=YOUR_API_KEY